The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Biora Inc. COM 74319F305   4,693,712 0 SH   SOLE   1,694,481 0 0
Biora Inc. Note 7.250% 12/0 74319FAB3   58,075,575 0 PRN   SOLE   0 0 103,500,000
Amryt Pharma PLC Sponsored ADS 03217L106   129,138,967 0 SH   SOLE   8,857,268 0 0
RVL PHARMACEUTICALS PLC SHS G6S41R101   16,644,506 0 SH   SOLE   14,600,444 0 0
Omeros Corp NOTE 6.250%11/1 682143AE2   11,109,890 0 PRN   SOLE   0 0 11,005,000
Omeros Corp NOTE 5.250% 2/1 682143AG7   46,503,087 0 PRN   SOLE   0 0 65,136,000
PUMA BIOTECHNOLOGY INC COM 74587V107   5,537,632 0 SH   SOLE   1,792,114 0 0
Paratek Pharmaceuticals Inc. NOTE 4.750% 5/0 699374AB0   7,415,205 0 PRN   SOLE   0 0 9,000,000